Potential Ameliorative Effects of Chromium Supplementation on Glucose Metabolism, Obesity, and Genomic Stability in Prediabetic Rat Model
- 25 July 2020
- journal article
- research article
- Published by Springer Nature in Biological Trace Element Research
- Vol. 199 (5), 1893-1899
- https://doi.org/10.1007/s12011-020-02299-1
Abstract
Chromium (III) (Cr(III)) effect on improving glucose, body mass loss, and genomic stability has been extensively studied in models of type 2 diabetes. However, there is a lack of studies evaluating its effect on prediabetes. Thus, this study evaluates the effects of Cr(III) as dietetic supplementation on glucose metabolism, obesity, and genomic stability on prediabetic rat model using high-invert sugar. Male Wistar rats were divided randomly into four treatment groups: (1) control, receiving standard diet (control); (2) prediabetic (PD), receiving a 32% of invert sugar; (3) Cr(III), receiving chromium (III) chloride (CrCl3•6H2O) (58.4 mg/L); and (4) Cr(III) + PD, receiving CrCl3•6H2O in combination with high-invert sugar. Cr(III) supplementation significantly reduced blood glucose (123.00 ± 8.29 mg/dL vs. 115.30 ± 9.31 mg/dL, p = 0.015) and partially reduced area under the 120-min blood glucose response curve (AUC) in PD rats (p = 0.227). Moreover, Cr(III) attenuated weight gain (187.29 ± 38.56 g vs. 167.22 ± 29.30 g, p = 0.004), significantly reducing body mass index (0.68 ± 0.04 g/cm2 vs. 0.63 ± 0.04 g/cm2, p < 0.001), Lee index (0.30 ± 0.01 vs. 0.28 ± 0.01, p < 0.001), and peritoneal fat (p < 0.001). Regarding genomic stability, high-invert sugar, Cr(III), or the combination of both did not produce changes in oxidative stress, DNA damage in pancreas, or cytotoxicity markers. These data suggest that Cr(III) supplementation improved partially glucose metabolism and reduced obesity in rat model PD due to high-invert sugar without influence in genomic stability.Keywords
Funding Information
- FAPERGS
- CNPq
This publication has 38 references indexed in Scilit:
- Advanced Glycation End Products and Oxidative Stress in Type 2 Diabetes MellitusBiomolecules, 2015
- Is chromium pharmacologically relevant?Journal of Trace Elements in Medicine and Biology, 2014
- Standards of Medical Care in Diabetes—2014Diabetes Care, 2013
- DNA damage and cytotoxicity in adult subjects with prediabetesMutation Research - Genetic Toxicology and Environmental Mutagenesis, 2013
- Pre-Diabetes, Metabolic Syndrome, and Cardiovascular RiskJournal of the American College of Cardiology, 2012
- Chromium and genomic stabilityMutation Research, 2011
- Sugar-Sweetened Beverages, Obesity, Type 2 Diabetes Mellitus, and Cardiovascular Disease RiskCirculation, 2010
- Anthropometrical parameters and markers of obesity in ratsLaboratory Animals, 2007
- [49] Determination of carbonyl content in oxidatively modified proteinsMethods in Enzymology, 1990
- CORRELATION BETWEEN 'LEE INDEX' AND CARCASS FAT CONTENT IN WEANLING AND ADULT FEMALE RATS WITH HYPOTHALAMIC LESIONSJournal of Endocrinology, 1968